Daily Stock Analysis, EW, Edwards Lifesciences Corp, priceseries

Edwards Lifesciences Corp. Daily Stock Analysis
Stock Information
Open
242.14
Close
245.64
High
245.95
Low
241.54
Previous Close
240.56
Daily Price Gain
5.08
YTD High
245.95
YTD High Date
Nov 15, 2019
YTD Low
140.86
YTD Low Date
Jan 3, 2019
YTD Price Change
96.40
YTD Gain
64.59%
52 Week High
245.95
52 Week High Date
Nov 15, 2019
52 Week Low
139.64
52 Week Low Date
Dec 24, 2018
52 Week Price Change
89.93
52 Week Gain
57.75%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 13. 2016
89.37
Jan 17. 2017
96.94
22 Trading Days
8.47%
Link
LONG
Apr 19. 2017
96.69
Jun 9. 2017
115.77
36 Trading Days
19.74%
Link
LONG
Nov 24. 2017
109.34
Dec 13. 2017
115.45
13 Trading Days
5.59%
Link
LONG
Jan 3. 2018
114.59
Feb 5. 2018
126.06
22 Trading Days
10.01%
Link
LONG
Jun 6. 2018
141.97
Jun 25. 2018
149.41
13 Trading Days
5.24%
Link
LONG
Sep 11. 2018
143.92
Oct 2. 2018
163.18
15 Trading Days
13.38%
Link
LONG
Mar 11. 2019
173.56
Apr 5. 2019
189.04
19 Trading Days
8.92%
Link
LONG
Jun 4. 2019
174.04
Jun 26. 2019
186.93
16 Trading Days
7.41%
Link
Company Information
Stock Symbol
EW
Exchange
NYSE
Company URL
http://www.edwards.com
Company Phone
9492502500
CEO
Michael A. Mussallem
Headquarters
California
Business Address
ONE EDWARDS WAY, IRVINE, CA 92614
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001099800
About

Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Description

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral replacement, and minimally invasive aortic heart valve system; and tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve. In addition, it produces pericardial valves from biologically inert animal tissue; and provides heart valve repair therapies, including annuloplasty rings and systems. Further, the company offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; pulmonary artery catheters; and Oximetry Central Venous Catheters for continuous measurement of central venous oxygen saturation. Additionally, its critical care products include disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection; and peripheral vascular products used to treat endolumenal occlusive disease, such as embolectomy catheters for removing blood clots from peripheral blood vessels. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.